Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-06

Clinical Trial Update: Role of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BK

View source ↗

Summary

A clinical trial update evaluating whether anti-BK virus neutralizing antibodies can serve as a prognostic marker for the development of BK virus nephropathy in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-BK Virus Neutralizing Antibodies

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Graft Dysfunction | Status: UNKNOWN